{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T03:58:45Z","timestamp":1777780725555,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["R01HL102214"],"award-info":[{"award-number":["R01HL102214"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.hrthm.2012.04.031","type":"journal-article","created":{"date-parts":[[2012,4,23]],"date-time":"2012-04-23T20:31:31Z","timestamp":1335213091000},"page":"1403-1408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Pharmacotherapy in Medicare beneficiaries with atrial fibrillation"],"prefix":"10.1016","volume":"9","author":[{"given":"Jonathan P.","family":"Piccini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojuan","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy A.","family":"DeWald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan S.","family":"Go","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian F.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley H.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2012.04.031_bib1","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0002-8703(96)90288-4","article-title":"Secular trends in the prevalence of atrial fibrillation: the Framingham Study","volume":"131","author":"Wolf","year":"1996","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2012.04.031_bib2","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2012.04.031_bib3","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2012.04.031_bib4","series-title":"Initial National Priorities for Comparative Effectiveness Research","year":"2009"},{"key":"10.1016\/j.hrthm.2012.04.031_bib5","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1161\/CIRCEP.109.856633","article-title":"Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials","volume":"2","author":"Piccini","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2012.04.031_bib6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/HCO.0b013e32833a524f","article-title":"Oral factor Xa inhibitors for the prevention of stroke in atrial fibrillation","volume":"25","author":"Piccini","year":"2010","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.hrthm.2012.04.031_bib8","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/01.mlr.0000160417.39497.a9","article-title":"Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors","volume":"43","author":"Birman-Deych","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.hrthm.2012.04.031_bib9","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.hrthm.2012.04.031_bib10","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2012.04.031_bib11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIR.0b013e3181fa3cf4","article-title":"2011 ACCF\/AHA\/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline): a Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"123","author":"Wann","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2012.04.031_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/CIRCOUTCOMES.110.958165","article-title":"Estimation of total incremental health care costs in patients with atrial fibrillation in the United States","volume":"4","author":"Kim","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.hrthm.2012.04.031_bib13","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jacc.2006.07.009","volume":"48","author":"Fuster","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2012.04.031_bib14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.amjcard.2009.10.012","article-title":"The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation","volume":"105","author":"Le Heuzey","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2012.04.031_bib15","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation","volume":"26","author":"Nieuwlaat","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2012.04.031_bib16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJM198702193160807","article-title":"Amiodarone","volume":"316","author":"Mason","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2012.04.031_bib17","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jacc.2009.04.085","article-title":"Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation","volume":"54","author":"Piccini","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2012.04.031_bib18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/europace\/eur029","article-title":"Mixed treatment comparisons for atrial fibrillation: evidence network or bewildering entanglement?","volume":"13","author":"Piccini","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2012.04.031_bib19","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/01.STR.0000208294.46968.a4","article-title":"Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation","volume":"37","author":"Birman-Deych","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.hrthm.2012.04.031_bib20","doi-asserted-by":"crossref","first-page":"927","DOI":"10.7326\/0003-4819-131-12-199912210-00004","article-title":"Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"131","author":"Go","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrthm.2012.04.031_bib21","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1136\/heartjnl-2011-300901","article-title":"Risk stratification schemes, anticoagulation use and outcomes: the risk\u2013treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation","volume":"97","author":"Sandhu","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2012.04.031_bib22","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2012.04.031_bib23","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.STR.0000174293.17959.a1","article-title":"Coding of stroke and stroke risk factors using International Classification of Diseases, Revisions 9 and 10","volume":"36","author":"Kokotailo","year":"2005","journal-title":"Stroke"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527112004195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527112004195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:44:30Z","timestamp":1761547470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527112004195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1547527112004195"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2012.04.031","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacotherapy in Medicare beneficiaries with atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2012.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}